Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brexpiprazole vs Aripiprazole in Adults With Acute Schizophrenia
NCT03874494Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- Nov 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brexpiprazole in schizophrenia, sponsored by Otsuka Holdings. Started Nov 2019; status: completed.
02
Drugs
brexpiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03874494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03874494.